Mechanism-independent method for predicting response to multidrug combinations in bacteria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 30, 2012, Pages 12254-12259

  Wood, Kevin ^a   Nishida, Satoshi ^a   Sontag, Eduardo D ^b   Cluzel, Philippe ^a  

^a HARVARD UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Dose response relationship; Entropy; Pairwise; Prokaryotes

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; CHLORAMPHENICOL; DOXYCYCLINE; ERYTHROMYCIN; KANAMYCIN; LINCOMYCIN; LINCOSAMIDE; MACROLIDE; OFLOXACIN; POLYPEPTIDE ANTIBIOTIC AGENT; PRESERVATIVE; PYRIMIDINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SALICYLIC ACID; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIUM; CONTROLLED STUDY; DRUG EFFECT; ENTROPY; ESCHERICHIA COLI; MULTIDRUG RESISTANCE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AMINOPYRIDINES; ANALGESICS; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; INHIBITORY CONCENTRATION 50; NUCLEIC ACID SYNTHESIS INHIBITORS; PHARMACOLOGY; PRESERVATIVES, PHARMACEUTICAL; PROTEIN SYNTHESIS INHIBITORS; STAPHYLOCOCCUS AUREUS; SULFONAMIDES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PROKARYOTA; STAPHYLOCOCCUS AUREUS;

EID: 84864369297     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201281109     Document Type: Article

References (32)

1. Baddour LM, et al. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America (2005) Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation 111:e394-e434.
2. Deresinski S (2009) Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 49:1072-1079.
3. Herbert D, et al. (1996) Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob Agents Chemother 40:2296-2299. (Pubitemid 26328035)
4. Mory F, Fougnot S, Rabaud C, Schuhmacher H, Lozniewski A (2005) In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections. J Antimicrob Chemother 55:265-268. (Pubitemid 40331157)
5. Bliss CI (1956) The calculation of microbial assays. Bacteriol Rev 20:243-258.
6. Loewe S (1953) The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3:285-290.
7. Greco WR, Bravo G, Parsons JC (1995) The search for synergy: A critical review from a response surface perspective. Pharmacol Rev 47:331-385.
8. Bollenbach T, Quan S, Chait R, Kishony R (2009) Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139:707-718.
9. Huovinen P, Wolfson JS, Hooper DC (1992) Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates. Eur J Clin Microbiol Infect Dis 11:255-257.
10. Cover TM, Thomas JA (2006) Elements of Information Theory, XXIII (Wiley-Interscience, Hoboken, NJ).
11. Jaynes ET (1957) Information theory and statistical mechanics. Phys Rev 106:620-630.
12. Isserlis L (1918) On a formula for the product-moment coefficient of any order of a normal frequency distribution in any number of variables. Biometrika 12:134-139.
13. Langlois R, Cantor CR, Vince R, Pestka S (1977) Interaction between the erythromycin and chloramphenicol binding sites on the Escherichica coli ribosome. Biochemistry 16:2349-2356. (Pubitemid 8123518)
14. Cohen SP, Levy SB, Foulds J, Rosner JL (1993) Salicylate induction of antibiotic resistance in Escherichia coli: Activation of the mar operon and a mar-independent pathway. J Bacteriol 175:7856-7862. (Pubitemid 24004391)
15. Haight TH, Finland M (1952) Laboratory and clinical studies on erythromycin. N Engl J Med 247:227-232.
16. Amari S (2001) Information geometry on hierarchy of probability distributions. IEEE Trans Inf Theory 47:1701-1711.
17. Schneidman E, Still S, Berry MJ, 2nd, Bialek W (2003) Network information and connected correlations. Phys Rev Lett 91:238701.
18. Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK (2006) Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 2:458-466. (Pubitemid 44266307)
19. Jonker DM, Visser SAG, van der Graaf PH, Voskuyl RA, Danhof M (2005) Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. Pharmacol Ther 106:1-18. (Pubitemid 40386718)
20. Keith CT, Borisy AA, Stockwell BR (2005) Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 4:71-78. (Pubitemid 40109591)
21. Kohanski MA, Dwyer DJ, Collins JJ (2010) How antibiotics kill bacteria: From targets to networks. Nat Rev Microbiol 8:423-435.
22. Lehár J, Stockwell BR, Giaever G, Nislow C (2008) Combination chemical genetics. Nat Chem Biol 4:674-681.
23. Lehár J, et al. (2007) Chemical combination effects predict connectivity in biological systems. Mol Syst Biol 3:80.
24. Geva-Zatorsky N, et al. (2010) Protein dynamics in drug combinations: A linear superposition of individual-drug responses. Cell 140:643-651.
25. Margolin AA, et al. (2006) ARACNE: An algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7 (Suppl 1):S7.
26. Mora T, Walczak AM, Bialek W, Callan CG, Jr. (2010) Maximum entropy models for antibody diversity. Proc Natl Acad Sci USA 107:5405-5410.
27. Shlens J, et al. (2009) The structure of large-scale synchronized firing in primate retina. J Neurosci 29:5022-5031.
28. Shlens J, et al. (2006) The structure of multi-neuron firing patterns in primate retina. J Neurosci 26:8254-8266. (Pubitemid 44309839)
29. Schneidman E, Berry MJ, 2nd, Segev R, Bialek W (2006) Weak pairwise correlations imply strongly correlated network states in a neural population. Nature 440:1007-1012.
30. Chatterjee MS, Purvis JE, Brass LF, Diamond SL (2010) Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli. Nat Biotechnol 28:727-732.
31. Baba T, et al. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: The Keio collection. Mol Syst Biol 2:2006-2008.
32. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K (2008) Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: Polymorphism and evolution of two major pathogenicity islands. J Bacteriol 190:300-310.